The US Bankruptcy Court granted an order for relief for liquidation under Chapter 7 for the involuntary petition filed against Generex Biotechnology Corp. on June 6, 2022. The debtor listed its assets of $338.41 million and liabilities of $521.63 million.
Generex Biotechnology Corporation
Equities
GNBT
US3714853013
Biotechnology & Medical Research
1st Jan change | Capi. | |
---|---|---|
+8.96% | 105B | |
-1.43% | 104B | |
+4.40% | 22.94B | |
-12.15% | 22.34B | |
-4.36% | 19.25B | |
-39.98% | 17.08B | |
-10.04% | 16.96B | |
+38.61% | 12.63B | |
+313.59% | 8.49B |